| US7048906B2 (en) | 1995-05-17 | 2006-05-23 | Cedars-Sinai Medical Center | Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions |
| US6281237B1 (en) | 1999-04-02 | 2001-08-28 | Neurogen Corporation | N-phenyl benzimidazolecarboxamide and N-phenyl indolecarboxamide derivatives |
| AU4055300A (en)* | 1999-04-02 | 2000-10-23 | Neurogen Corporation | Aryl and heteroaryl fused aminoalkyl-imidazole derivatives: selective modulators of Bradykinin B2 receptors |
| JP2004510765A (en)* | 2000-10-06 | 2004-04-08 | ニューロジェン・コーポレーション | Benzimidazole and indole derivatives as CRF receptor modulators |
| PA8535601A1 (en) | 2000-12-21 | 2002-11-28 | Pfizer | BENZIMIDAZOL AND PIRIDILIMIDAZOL DERIVATIVES AS LIGANDOS FOR GABAA |
| UA74912C2 (en) | 2001-07-06 | 2006-02-15 | Merck & Co Inc | Beta-aminotetrahydroimidazo-(1,2-a)-pyrazines and tetratriazolo-(4,3-a)-pyrazines as inhibitors of dipeptylpeptidase for the treatment or prevention of diabetes |
| ATE419863T1 (en) | 2001-09-24 | 2009-01-15 | Imp Innovations Ltd | PYY3-36 FOR REDUCING OR PREVENTING OBESITY |
| AU2003201998C1 (en) | 2002-01-10 | 2012-10-25 | Imperial Innovations Limited | Modification of feeding behavior |
| EP1465888A2 (en) | 2002-01-10 | 2004-10-13 | Neurogen Corporation | Melanin concentrating hormone receptor ligands: substituted benzoimidazole analogues |
| GB0300571D0 (en) | 2003-01-10 | 2003-02-12 | Imp College Innovations Ltd | Modification of feeding behaviour |
| JP2008502721A (en) | 2004-05-21 | 2008-01-31 | ノバルティス ヴァクシンズ アンド ダイアグノスティクス， インコーポレイテッド | Substituted quinoline derivatives as mitotic kinesin inhibitors |
| MXPA06014909A (en) | 2004-06-18 | 2007-02-28 | Chiron Corp | N- (1- (1-benzyl -4-phenyl-1h-imidazol-2-yl) -2,2-dymethylpropyl) benzamide derivatives and related compounds as kinesin spindle protein (ksp) inhibitors for the treatment of cancer. |
| CN101233115A (en) | 2004-10-19 | 2008-07-30 | 诺华疫苗和诊断公司 | Indole and benzimidazole derivatives |
| KR101387910B1 (en) | 2005-01-10 | 2014-04-25 | 콜텐도 인베스트 아베 | Methods and compositions for treating diabetes, metabolic syndrome and other conditions |
| EP1910317B1 (en) | 2005-07-20 | 2013-07-03 | Eli Lilly And Company | 1-amino linked compounds |
| NZ576569A (en) | 2006-10-02 | 2012-05-25 | Cortendo Ab Publ | Ketoconazole enantiomer in humans |
| ES2557478T3 (en) | 2006-11-13 | 2016-01-26 | Novartis Ag | Pyrazole and triazole compounds as KSP inhibitors |
| TWI428346B (en) | 2006-12-13 | 2014-03-01 | Imp Innovations Ltd | Novel compounds and their effects on feeding behaviour |
| EP1935420A1 (en) | 2006-12-21 | 2008-06-25 | Merck Sante | 2-Adamantyl-butyramide derivatives as selective 11beta-HSD1 inhibitors |
| EA200900924A1 (en) | 2007-01-05 | 2009-12-30 | Новартис Аг | CYCLIZED DERIVATIVES AS EG-5 INHIBITORS |
| WO2008145596A1 (en)* | 2007-06-01 | 2008-12-04 | F. Hoffmann-La Roche Ag | Piperidine-amide derivatives |
| EP2110374A1 (en) | 2008-04-18 | 2009-10-21 | Merck Sante | Benzofurane, benzothiophene, benzothiazol derivatives as FXR modulators |
| US8759539B2 (en) | 2008-11-17 | 2014-06-24 | Merck Sharp & Dohme Corp. | Substituted bicyclic amines for the treatment of diabetes |
| CA2768577A1 (en) | 2009-07-23 | 2011-01-27 | Schering Corporation | Benzo-fused oxazepine compounds as stearoyl-coenzyme a delta-9 desaturase inhibitors |
| WO2011011506A1 (en) | 2009-07-23 | 2011-01-27 | Schering Corporation | Spirocyclic oxazepine compounds as stearoyl-coenzyme a delta-9 desaturase inhibitors |
| JP2013510834A (en) | 2009-11-16 | 2013-03-28 | メリテク | [1,5] -diazocine derivatives |
| CN102791701B (en) | 2009-12-30 | 2014-02-12 | 深圳信立泰药业股份有限公司 | 3-(3-Aminopiperidin-1-yl)-5-oxo-1,2,4-triazine derivatives as inhibitors of dipeptidyl peptidase IV (DPP-IV) |
| AU2013248880A1 (en) | 2012-04-16 | 2014-11-06 | Kaneq Pharma Inc. | Fused aromatic phosphonate derivatives as precursors to PTP-1B inhibitors |
| US20150246117A1 (en) | 2012-09-24 | 2015-09-03 | Ulf Eriksson | Treatment of type 2 diabetes and related conditions |
| EP3863634A1 (en) | 2018-10-12 | 2021-08-18 | Strongbridge Dublin Limited | Levoketoconazole for treatment of congenital adrenal hyperplasia and primary aldosteronism |
| WO2025057134A2 (en) | 2023-09-14 | 2025-03-20 | Ascletis Pharma (China) Co., Limited | Glp-1r agonist and therapeutic method thereof |
| US12291530B1 (en) | 2023-11-24 | 2025-05-06 | Ascletis Pharma (China) Co., Limited | GLP-1R agonist and therapeutic method thereof |